资讯

Baylor College of Medicine22 小时
Understanding what makes some bladder cancers resistant to chemotherapy
About one quarter of patients with muscle-invasive bladder cancer (MIBC) may be treated and derive a benefit with the current ...
GEN - Genetic Engineering and Biotechnology News23 小时
Reading the Masterminds of the Human Body
Stem cells differentiated into brain and neural organoids may help scientists understand both brain development and ...
Researchers identify protein patterns linked to chemotherapy resistance in bladder cancer
About one quarter of patients with muscle-invasive bladder cancer (MIBC) may be treated and derive a benefit with the current ...
Chromatography Online1 天
Purifying Immunoglobulin-Based Therapies Using Cation Exchange Techniques
Researchers created a pH-gradient cation exchange separation to purify IgG2 disulfide isoforms in their native state. The pH-gradient cation exchange method can be used as a potential alternative for ...
PharmaTimes4 天
Exonate to launch phase 2b trial of EXN407 for diabetic eye disease
Exonate has announced plans to initiate a phase 2b clinical trial of its lead candidate EXN407, a topical SRPK1 inhibitor, ...
UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology
Klotho Neurosciences, Inc. (NASDAQ: KLTO) (the "Company" or "Klotho") announced that it is evaluating the acquisition of ...
The American Journal of Managed Care8 天
TP53 Mutations Remain Important Research Focus in Cancer
TP53 mutations can have a significant impact on the prognosis of diseases like chronic lymphocytic leukemia, but their effect ...
The Bakersfield Californian8 天
Celcuity Announces First Patient Dosed in Phase 3 VIKTORIA-2 Clinical Trial of Gedatolisib ...
Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that the first patient has been ...